Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity

Published:2012-12 Issue:6 Volume:2 Page:1697-1709
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Huffaker Thomas B.,Hu Ruozhen,Runtsch Marah C.,Bake Erin,Chen Xinjian,Zhao Jimmy,Round June L.,Baltimore David,O'Connell Ryan M.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference42 articles.

1. Neurotensin signaling activates microRNAs-21 and 155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors;Bakirtzi;Gastroenterology,2011

2. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice;Boldin;J. Exp. Med.,2011

3. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155;Chang;Nat. Med.,2011

4. Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer;Cubillos-Ruiz;Cancer Res.,2012

5. Inciting inflammation: the RAGE about tumor promotion;Dougan;J. Exp. Med.,2008

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer;Cells;2024-08-13

2. MicroRNAs: a symphony orchestrating evolution and disease dynamics;Trends in Molecular Medicine;2024-08

3. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy;Journal of Nanobiotechnology;2024-07-08

4. Functionalized nanowires for miRNA-mediated therapeutic programming of naïve T cells;Nature Nanotechnology;2024-04-29

5. miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review;International Journal of Molecular Sciences;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3